Kelley E. McQueeney
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Galectins and Cancer Biology
Papers in
-
- Protein Tyrosine Phosphatases 8
- Biochemical and Molecular Research 2
- ATP Synthase and ATPases Research 2
- Peroxisome Proliferator-Activated Receptors 1
-
- Galectins and Cancer Biology 4
- Co-authors
- John S. Lazo (8 shared papers)Elizabeth R. Sharlow (7 shared papers)Peter Wipf (6 shared papers)Joseph M. Salamoun (3 shared papers)James C. Burnett (2 shared papers)Jeffrey S. Isenberg (1 shared paper)Bruce R. Pitt (1 shared paper)Steven J. Geib (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Science Signaling (2 papers)Expert Opinion on Investigational Drugs (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- United StatesBrazilJapan
In The Last Decade
Kelley E. McQueeney
14 papers receiving 329 citations
Peers
Comparison fields: 5 of 62
- Toxicology 19
- Immunology 91
- Molecular Biology 253
- Biochemistry 21
- Oncology 55
Countries citing papers authored by Kelley E. McQueeney
This map shows the geographic impact of Kelley E. McQueeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley E. McQueeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley E. McQueeney more than expected).
Fields of papers citing papers by Kelley E. McQueeney
This network shows the impact of papers produced by Kelley E. McQueeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley E. McQueeney. The network helps show where Kelley E. McQueeney may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelley E. McQueeney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 2020 | 43 | |
| 3 | 2016 | 43 | |
| 4 | 2017 | 35 | |
| 5 | 2014 | 31 | |
| 6 | 2017 | 31 | |
| 7 | 2017 | 27 | |
| 8 | 2021 | 23 | |
| 9 | 2018 | 15 | |
| 10 | 2014 | 15 | |
| 11 | 2020 | 11 | |
| 12 | 2016 | 8 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 |
About Kelley E. McQueeney
Kelley E. McQueeney is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Toxicology, having authored 14 papers that have together received 329 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (8 papers), Galectins and Cancer Biology (4 papers), Cancer Genomics and Diagnostics (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Biochemical and Molecular Research (2 papers), ATP Synthase and ATPases Research (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper) and Trypanosoma species research and implications (1 paper). The work is most often cited by research in Toxicology (19 citations), Immunology (91 citations), Molecular Biology (253 citations), Biochemistry (21 citations) and Oncology (55 citations). Kelley E. McQueeney has collaborated with scholars based in United States, Brazil and Japan. Frequent co-authors include John S. Lazo, Elizabeth R. Sharlow, Peter Wipf, Joseph M. Salamoun, James C. Burnett, Jeffrey S. Isenberg, Bruce R. Pitt, Steven J. Geib, Gregg E. Homanics and Mark W. Zimmerman. Their work appears in journals such as Journal of Biological Chemistry, Science Signaling, Expert Opinion on Investigational Drugs, The International Journal of Biochemistry & Cell Biology and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.